Quantitatively immunological characterization of mogamulizumab skin disorders in ATL patients

• Hlavní autoři: Asahi Ito (Autor), Yui Suzuki (Autor), Ayako Masaki (Autor), Shinichiro Yoshida (Autor), Hitoshi Suzushima (Autor), Shigeki Takemoto (Autor), Atae Utsunomiya (Autor), Toshihiko Ishii (Autor), Masanori Hiura (Autor), Takeshi Takahashi (Autor), Satoshi Yurimoto (Autor), Hiroshi Inagaki (Autor), Akimichi Morita (Autor), Shinsuke Iida (Autor), Takashi Ishida (Autor)
• Médium: Kniha
• Vydáno: Frontiers Media S.A., 2019-08-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

Abstract Purpose Skin disorders demonstrate highly variable phenotypical and histopathological features. Mogamulizumab, a humanized anti‐CC chemokine receptor 4 monoclonal antibody indicated for the treatment of adult T‐cell leukemia‐lymphoma, has been shown to induce skin‐related adverse events in...